Clinical trial of experimental coronavirus vaccine expected to start in April


The National Institute of Allergy and Infectious Diseases is expected to soon launch a clinical trial of an experimental coronavirus vaccine.
The vaccine was developed by the drugmaker Moderna, and researchers hope to begin testing it on humans in late April. The first trial will involve 20 to 25 healthy volunteers, with results expected by July or August. If that round is successful, a second trial will include hundreds or thousands of subjects. The vaccine was created after the coronavirus' genetic sequence was determined in January.
"Going into a Phase One trial within three months of getting the sequence is unquestionably the world indoor record," NIAID Director Anthony Fauci told The Wall Street Journal on Monday. "Nothing has ever gone that fast."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Gene-based technology has yet to result in an approved vaccine for humans, the Journal reports. If this vaccine does work, it will still have to go through regulatory measures, and likely won't be widely available until 2021. Fauci said the virus might not spread as quickly in the summer due to the heat, but could roar back in the winter. More than 2,600 people have died in this coronavirus outbreak, and there are more than 79,000 confirmed cases worldwide, with most in China.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
What to know before turning to AI for financial advice
the explainer It can help you crunch the numbers — but it might also pocket your data
-
Book reviews: 'The Headache: The Science of a Most Confounding Affliction—and a Search for Relief' and 'Tonight in Jungleland: The Making of Born to Run'
Feature The search for a headache cure and revisiting Springsteen's 'Born to Run' album on its 50th anniversary
-
Keith McNally' 6 favorite books that have ambitious characters
Feature The London-born restaurateur recommends works by Leo Tolstoy, John le Carré, and more
-
Florida erases rainbow crosswalk at Pulse nightclub
Speed Read The colorful crosswalk was outside the former LGBTQ nightclub where 49 people were killed in a 2016 shooting
-
Trump says Smithsonian too focused on slavery's ills
Speed Read The president would prefer the museum to highlight 'success,' 'brightness' and 'the future'
-
Trump to host Kennedy Honors for Kiss, Stallone
Speed Read Actor Sylvester Stallone and the glam-rock band Kiss were among those named as this year's inductees
-
White House seeks to bend Smithsonian to Trump's view
Speed Read The Smithsonian Institution's 21 museums are under review to ensure their content aligns with the president's interpretation of American history
-
Charlamagne Tha God irks Trump with Epstein talk
Speed Read The radio host said the Jeffrey Epstein scandal could help 'traditional conservatives' take back the Republican Party
-
CBS cancels Colbert's 'Late Show'
Speed Read 'The Late Show with Stephen Colbert' is ending next year
-
A long weekend in Zürich
The Week Recommends The vibrant Swiss city is far more than just a banking hub
-
Why Irish traditional music is having a moment
In The Spotlight Frustrations with isolation and technology credited for reviving 'auld' trad tunes